NCT02968602View on ClinicalTrials.gov

Minocycline and Tobacco Craving in Smokers With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

July 23, 2019

Study Completion Date

July 23, 2019

Conditions
SchizophreniaTobacco Use
Interventions
DRUG

Minocycline

Minocycline capsules taken twice daily for two weeks.

OTHER

Placebo

Placebo capsules taken twice daily for two weeks.

Trial Locations (1)

21228

Maryland Psyciatric Research Center, Catonsville

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT02968602 - Minocycline and Tobacco Craving in Smokers With Schizophrenia | Biotech Hunter | Biotech Hunter